TNFRSF13C and type 1 diabetes mellitus: BAFF receptor (BAFFR)-Fc treatment inhibited T1D development; B cells remaining after BAFFR-Fc treatment had a diminished capacity to present autoantigens to diabetogenic T cells and exhibited a regulatory phenotype [95].